US Stock MarketDetailed Quotes

LIANY LianBio

Watchlist
  • 0.318
  • -0.006-1.85%
15min DelayClose Jun 20 16:00 ET
  • 0.317
  • -0.001-0.28%
Post 16:01 ET
34.36MMarket Cap-387P/E (TTM)

About LianBio Company

LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.

Company Profile

SymbolLIANY
Company NameLianBio
Listing DateNov 1, 2021
Issue Price16.00
Founded2019
CEOMr. Adam Stone
MarketPink Market
Employees52
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address103 Carnegie Center Drive,Suite 309
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-609-486-2308
Websitehttp://www.lianbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Adam Stone
  • Director and Interim Chief Executive Officer
  • 62.07K
  • Brianne Jahn
  • Chief Business Officer
  • --
  • Ehong Gu
  • Interim Chief Financial Officer and Vice President, Head of Global Finance
  • --
  • Pascal Qian
  • General Manager, China and Senior Vice President
  • --
  • Konstantin Poukalov
  • Executive Chairman of the Board
  • 62.07K
  • Neil Kumar, PhD
  • Director
  • --
  • Susan Silbermann
  • Independent Director
  • 121.44K
  • Tassos Gianakakos
  • Independent Director
  • 128.07K
  • Wei Wei Chen
  • Independent Director
  • 285.89K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg